Teva falls sharply on disappointing 2025 guidance

Teva CEO Richard Francis credit: Elad Malka
Teva CEO Richard Francis credit: Elad Malka

The Israeli pharmaceuticals company reported strong fourth quarter results but its 2025 outlook did not meet expectations.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has opened the reporting season for Israeli companies by publishing its fourth quarter and full year 2024 financial results.

In the fourth quarter the company reported revenue of $4.2 billion and non-GAAP earning per share of $0.71, above the analysts' expectations. Revenue in full year 2024 was $16.5 billion, at the upper end of $16.1-16.5 billion guidance, and 4.4% higher than 2023 revenue. Non-GAAP earnings per share in 2024 was $2.49 (the company's guidance was $2.40-2.50). However, the company's share price opened nearly 10% lower on the NYSE due to a disappointing 2025 outlook.

Teva has also provided guidance on 2025 for the first time. The company forecasts 2025 revenue of $16.8-17.4 billion, representing annual growth of 3.6% and non-GAAP earnings per share of $2.35-2.65. The analysts' consensus was for annual revenue of $17.1 billion and non-GAAP earnings per share of $2.78, so that the profit guidance is below expectations.

Teva CEO Richard Francis said, "2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products and key innovative products. Focusing on rigorous execution of our Pivot to Growth strategy throughout the year, we continued to achieve important milestones in each of its four pillars, including surpassing the outlook for our key innovative products, growing our generics business across all segments, and accelerating our early-stage innovative pipeline, including the positive Phase 2b results for our duvakitug (anti-Tl1A) asset. These results pave the way for pivotal trials in Crohn’s disease and ulcerative colitis, as well as, potentially, other Immunological and fibrotic indications beyond, in collaboration with our partner, Sanofi."

He added, "In 2025, we anticipate further progress in our key innovative growth drivers, while also executing on our complex generics and biosimilars business, supported by new product launches. We are also excited to advance to Phase 3 trials for our duvakitug (anti-TL1A) asset."

Overall 2024 was a successful year for Teva. The share price rose 111% during the year, giving it a market cap of $25 billion, making it once again Israel's most valuable company. The share price was boosted by the positive results for duvakitug, for the treatment of Crohn's disease, which it is developing with Sanofi.

Published by Globes, Israel business news - en.globes.co.il - on January 29, 2025.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2025.

Teva CEO Richard Francis credit: Elad Malka
Teva CEO Richard Francis credit: Elad Malka
Tel Aviv credit: Shutterstock Meitav sees Israel housing prices falling

More Israeli households are expected to prefer renting a home rather than buying their own apartment and the consequences will be negative, Meitav investment house chief economist Alex Zabezhinsky predicts.

Sasha Troufanov credit: IDF Spokesperson Amazon CEO welcomes release of employee Sasha Troufanov

Andy Jassy said that Amazon has not commented publicly on the hostages for fear that it would negatively impact their ability to be released, or how they were treated in captivity.

Israeli apartments Credit: Shutterstock Apartments sold and rented

A selection of recent real estate deals in Israel in Tel Aviv, Ra'anana, Netanya, Mazkeret Batya, Maalot-Tarshisha and Beersheva.

MK 84 bombs credit: Reuters IMAGO US shipment of MK-84 900 kilogram bombs arrives in Israel

One of the first steps taken by US President Donald Trump was to release the heavy deep-penetration bombs, which former President Joe Biden had halted the supply of.

BIG Glilot credit: Tel Aviv online BIG Glilot - Israel's biggest shopping center set to open

The shopping center will send shockwaves throughout the retail sector in Tel Aviv and the Sharon region and could put some of the area's malls out of business.

Inflation credit: Tali Bogdanovsky January CPI reading lifts inflation, housing prices rise

In the twelve months to the end of January 2024, inflation has risen to 3.8%, the Central Bureau of Statistics reports.

Credit Card payment terminal credit: Seika Chujo Shutterstock Cyberattack again disrupts Israel's credit card payments

Check Point chief of staff Gil Messing: "These are the capabilities of a state actor. This does not necessarily mean Iran, but in the past Iranian entities have been behind such attacks.

CyberArk offices credit: Eyal Izhar CyberArk buys US co Zilla Security, reports strong Q4

CyberArk, which will pay $165 million for the US identity governance and administration company, has surpassed Teva to become Israel's second most valuable company.

mSphere credit: Mer Group Mer launches armored vehicle awareness protection system

mSphere's comprehensive monitoring eliminates blind spots, enhances detection capabilities, and enables crews to identify and respond to potential threats swiftly and accurately.

Mortgage taking credit: Shutterstock Steep fall in mortgage taking in Israel in January

Mortgage taking was down 50% from the preceding month but up 30% from January 2024, the Bank of Israel reports.

Shekel-dollar ASAP Creative Shekel rebounds against dollar

Bank Leumi: The possibility of further appreciation of the shekel, raises the question of whether portfolio owners with high exposure to foreign exchange have a reason to hedge their investment portfolio.

Amnon Shashua  credit: Eyal Izhar Shashua's Mentee Robotics unveils robot for manual work

MenteeBot V3.0 takes on lifting tasks that would typically be strenuous for human workers over extended periods.

New housing credit: Satenik Guzhanina Shutterstock 50% of housing deals in 2024 were developer loans

What made 2024 distinct was that 50% of deals involved special offers by contractors and developers for apartments not yet built, the Ministry of Finance reports.

Donald Trump  credit: Reuters/Brendan McDermid Trump administration reaffirms AI chip restrictions on Israel

Sources say the US will demand Israel passes regulations to prevent tech leakage to China and may even include removal of the restrictions as part of a multilateral Middle East agreement.

Accountant General Yali Rothenberg credit: Cadya Levy Israel raises $5b international bond

Accountant General: This is an important public offering that indicates the financial stability of the State of Israel and the high confidence of global investors in the Israeli economy.

Check Point Chairman Gil Shwed and CEO Nadav Zafrir credit: Check Point Check Point teams with Wiz to challenge Palo Alto

The veteran cybersecurity company has formed a strategic partnership with Israeli company Wiz to provide end-to-end cloud security.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018